TCI Wealth Advisors’s Enfusion, Inc. ENFN Stock Holding History

TCI Wealth Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-357	Closed	-$3.75K	–	2341
2023 Q1	$3.75K	Hold	357	–	–	﹤0.01%	1725
2022 Q4	$3.45K	Buy	+357	New	+$4.02K	﹤0.01%	1776
2022 Q2	–	Sell	-281	Closed	-$4K	–	2560
2022 Q1	$4K	Buy	+281	New	+$4.29K	﹤0.01%	1817

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

TCI Wealth Advisors's ENFN Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Enfusion, Inc. (ENFN) in Q2 2023, closing a stake of 357 shares — an estimated $3.75K sold.

TCI Wealth Advisors first reported a position in ENFN in Q1 2022 and held it in 3 quarters. The position peaked at $4K in Q1 2022. 83 funds tracked by Wall St. Rank hold ENFN as of Q2 2023.

TCI Wealth Advisors reported no remaining Enfusion, Inc. position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 357 Enfusion, Inc. shares in Q2 2023, an estimated $3.75K.
TCI Wealth Advisors first reported a position in Enfusion, Inc. in Q1 2022 and held it in 3 quarters.
TCI Wealth Advisors's Enfusion, Inc. position peaked at $4K in Q1 2022.
83 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.